Valneva SE (VALN) Shares Outstanding (2019 - 2026)

Valneva SE (VALN) posted quarterly Shares Outstanding (Entity) of $95.7 million for Q4 2025, up 15.42% year-on-year from $82.9 million in Q4 2024, and down 1.18% on a QoQ basis from $96.8 million in Q2 2025.

Valneva SE (VALN) Shares Outstanding (2019 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Shares Outstanding (Entity) for 7 consecutive years, with $95.7 million the latest figure, recorded in Q4 2025.

  • Quarterly Shares Outstanding (Entity) rose 15.42% year-over-year to $95.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $95.7 million (up 15.42% YoY) and the FY2025 annual result came in at $95.7 million, up 15.42% from the prior year.
  • Shares Outstanding (Entity) slipped to $95.7 million in Q4 2025 per VALN's latest filing, from $96.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Entity) for VALN reached as high as $96.8 million in Q2 2025 and fell as low as $634389.0 in Q2 2022.
  • A 5-year average of $66.3 million and a median of $66.2 million in 2022 frame the typical range for Shares Outstanding (Entity).
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) plunged 98.88% — and 2023, when it jumped 12357.5%.
  • Year by year, Shares Outstanding (Entity) stood at $55.5 million in 2021, then climbed by 18.29% to $65.7 million in 2022, then gained by 20.05% to $78.9 million in 2023, then rose by 5.11% to $82.9 million in 2024, then rose by 15.42% to $95.7 million in 2025.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $95.7 million, $96.8 million, and $82.9 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6,012.74 Bn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 47.82 Bn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.44 Bn
4 NuCana 279.75 Bn 279.75 Bn - 11.23 Bn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 254.10 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 400.00 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 62.19 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 198.10 Mn
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn 168.18 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 168.18 Mn
Dec 31, 2025 168.18 Mn
Sep 30, 2025 145.71 Mn
Jun 30, 2025 145.71 Mn
Mar 31, 2025 145.71 Mn
Dec 31, 2024 145.71 Mn
Sep 30, 2024 138.62 Mn
Jun 30, 2024 138.62 Mn
Mar 31, 2024 138.62 Mn
Dec 31, 2023 138.62 Mn
Sep 30, 2023 115.47 Mn
Jun 30, 2023 115.47 Mn
Mar 31, 2023 115.47 Mn
Dec 31, 2022 115.47 Mn
Sep 30, 2022 1.11 Mn
Jun 30, 2022 1.11 Mn
Mar 31, 2022 97.62 Mn
Dec 31, 2021 97.62 Mn
Sep 30, 2021 90.76 Mn
Jun 30, 2021 90.76 Mn